MedPath

The effect of Aliskiren for microalbminurea of diabetic patients

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000005561
Lead Sponsor
Yamamoto General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

The cardiovascular events within 6months The serum creatinin is more than 2.0/1. 5 in male/female severe hypertension(more than 180/110mmHg the dicision of main doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Microalbuminuria
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath